Matches in Nanopublications for { ?s ?p "[Exon 20 PIK3CA mutations decreases survival in aggressive (HER-2 positive) breast carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP68283.RA3xc4f_kf8Pd9jsfxVzP1lGbc4azeDbi-mjZdA3M79vA130_assertion description "[Exon 20 PIK3CA mutations decreases survival in aggressive (HER-2 positive) breast carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP68283.RA3xc4f_kf8Pd9jsfxVzP1lGbc4azeDbi-mjZdA3M79vA130_provenance.
- assertion description "[Exon 20 PIK3CA mutations decreases survival in aggressive (HER-2 positive) breast carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Exon 20 PIK3CA mutations decreases survival in aggressive (HER-2 positive) breast carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Exon 20 PIK3CA mutations decreases survival in aggressive (HER-2 positive) breast carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP88796.RAluYig9lWY_ls8lUiiAq92jgkMnUEen9biLVYUUneztI130_assertion description "[Exon 20 PIK3CA mutations decreases survival in aggressive (HER-2 positive) breast carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP88796.RAluYig9lWY_ls8lUiiAq92jgkMnUEen9biLVYUUneztI130_provenance.
- NP686019.RAQgz3QMuaXmSctrvNrOnTeggVtCyQFOq9GnZuAzdy75s130_assertion description "[Exon 20 PIK3CA mutations decreases survival in aggressive (HER-2 positive) breast carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP686019.RAQgz3QMuaXmSctrvNrOnTeggVtCyQFOq9GnZuAzdy75s130_provenance.
- NP128083.RACo5Lvs_7e71O16S-yGSCSoGtfYlkAOhiiZeurJa-hmc130_assertion description "[Exon 20 PIK3CA mutations decreases survival in aggressive (HER-2 positive) breast carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP128083.RACo5Lvs_7e71O16S-yGSCSoGtfYlkAOhiiZeurJa-hmc130_provenance.
- NP686020.RAx0jFC4KPwcIReVzyLYKwlkO1IocZkmbQ8FYoN16EJH4130_assertion description "[Exon 20 PIK3CA mutations decreases survival in aggressive (HER-2 positive) breast carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP686020.RAx0jFC4KPwcIReVzyLYKwlkO1IocZkmbQ8FYoN16EJH4130_provenance.